456 related articles for article (PubMed ID: 1538587)
1. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
Williams CL; Hay JE; Huiatt TW; Lennon VA
Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
[TBL] [Abstract][Full Text] [Related]
2. [Serum anti-titin antibody in patients with myasthenia gravis].
Li YF; Zhang JB; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
[TBL] [Abstract][Full Text] [Related]
3. Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.
Williams CL; Lennon VA
J Exp Med; 1986 Oct; 164(4):1043-59. PubMed ID: 3020150
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire.
Victor KD; Pascual V; Williams CL; Lennon VA; Capra JD
Eur J Immunol; 1992 Sep; 22(9):2231-6. PubMed ID: 1516616
[TBL] [Abstract][Full Text] [Related]
5. Serum antibodies and monoclonal antibodies secreted by thymic B-cell clones from patients with myasthenia gravis define striational antigens.
Williams CL; Lennon VA; Momoi MY; Howard FM
Ann N Y Acad Sci; 1987; 505():168-79. PubMed ID: 3500666
[TBL] [Abstract][Full Text] [Related]
6. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis].
Wilisch A; Schultz A; Greiner A; Kirchner T; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():261-6. PubMed ID: 9065023
[TBL] [Abstract][Full Text] [Related]
8. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
Suzuki S
Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
[TBL] [Abstract][Full Text] [Related]
9. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
Aarli JA; Stefansson K; Marton LS; Wollmann RL
Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
[TBL] [Abstract][Full Text] [Related]
10. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
11. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
[TBL] [Abstract][Full Text] [Related]
12. Striational antibodies in a paraneoplastic context.
McKeon A; Lennon VA; LaChance DH; Klein CJ; Pittock SJ
Muscle Nerve; 2013 Apr; 47(4):585-7. PubMed ID: 23463255
[TBL] [Abstract][Full Text] [Related]
13. [Anti-Titin-antibodies at the patients with myasthenic and non-myasthenic thymoma].
Vetshev PS; Sanadze AG; Sidnev DV; Ippolitov LI; Zhivotov VA; Ablitsov AIu
Khirurgiia (Mosk); 2007; (6):53-6. PubMed ID: 17690667
[TBL] [Abstract][Full Text] [Related]
14. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
[TBL] [Abstract][Full Text] [Related]
15. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.
Marx A; Wilisch A; Schultz A; Greiner A; Magi B; Pallini V; Schalke B; Toyka K; Nix W; Kirchner T; Müller-Hermelink HK
Am J Pathol; 1996 Jun; 148(6):1839-50. PubMed ID: 8669470
[TBL] [Abstract][Full Text] [Related]
16. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
17. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
Romi F; Skeie GO; Gilhus NE; Aarli JA
Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
[TBL] [Abstract][Full Text] [Related]
18. [The significance of Titin antibody in diagnosing myasthenia gravis with thymoma].
Chen X; Lü C; Qiao J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1118-20. PubMed ID: 11766610
[TBL] [Abstract][Full Text] [Related]
19. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
20. Anti-titin antibodies are not associated with a specific thymoma histology.
Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
